{"id":275809,"date":"2026-09-29T09:29:12","date_gmt":"2026-09-29T03:59:12","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=275809"},"modified":"2026-09-29T09:29:12","modified_gmt":"2026-09-29T03:59:12","slug":"why-ind-swift-laboratories-ltd-share-near-52-week-consecutive-high-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-ind-swift-laboratories-ltd-share-near-52-week-consecutive-high-2026\/","title":{"rendered":"Ind-Swift Laboratories Ltd. (INDSWFTLA) 52 Week High Streak: Second Straight Session Near Peak"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/indswftla\/ind-share-price-today\">Ind-Swift Laboratories Ltd. (INDSWFTLA)<\/a> share price is trading within 2% of its 52-week high today and stood at Rs 416.25, up 1.95% from the previous close. Market cap was Rs 3,518.03 crore.<\/em><\/div>\n<p style=\"margin-top:0!important;margin-bottom:0!important;\"><a href=\"https:\/\/univest.in\/stocks\/indswftla\/ind-share-price-today\">Ind-Swift Laboratories Ltd.<\/a> 52 Week High Streak is now in its <strong>second straight session<\/strong>, with the stock trading near its 52-week high after a <strong>2.89%<\/strong> move across the streak. The latest peak stood at <strong>Rs 417.70<\/strong>, while the current price was <strong>Rs 416.25<\/strong> as of <strong>29 September 2026 at 9:23 AM IST<\/strong>. The latest Univest figures confirm the repeated-near-high pattern, but they do not establish a company-specific catalyst for the continued move.<\/p>\n<p style=\"margin-top:0!important;\">The previous close was <strong>Rs 408.30<\/strong>, the day opened at <strong>Rs 400.15<\/strong> and the low was also <strong>Rs 400.15<\/strong>. The market capitalisation stood at <strong>Rs 3,518.03 crore<\/strong>. For readers tracking Ind-Swift Laboratories Ltd. Share Price, the key point is that a repeated high pattern carries a different signal from a one-day move because it shows persistence near the yearly peak, not just a single intraday visit.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-ind-swift-laboratories-ltd-share-near-52-week-consecutive-high-2026\/#Ind-Swift_Laboratories_Ltd_52_Week_High_Streak_Consecutive_High_Analysis\" title=\"Ind-Swift Laboratories Ltd. 52 Week High Streak: Consecutive High Analysis\">Ind-Swift Laboratories Ltd. 52 Week High Streak: Consecutive High Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-ind-swift-laboratories-ltd-share-near-52-week-consecutive-high-2026\/#What_the_Repeated_52-Week_Highs_Show\" title=\"What the Repeated 52-Week Highs Show\">What the Repeated 52-Week Highs Show<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-ind-swift-laboratories-ltd-share-near-52-week-consecutive-high-2026\/#Ind-Swift_Laboratories_Ltd_INDSWFTLA_Fundamental_Analysis\" title=\"Ind-Swift Laboratories Ltd. (INDSWFTLA) Fundamental Analysis\">Ind-Swift Laboratories Ltd. (INDSWFTLA) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-ind-swift-laboratories-ltd-share-near-52-week-consecutive-high-2026\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-ind-swift-laboratories-ltd-share-near-52-week-consecutive-high-2026\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-ind-swift-laboratories-ltd-share-near-52-week-consecutive-high-2026\/#Why_Investors_Are_Watching_Ind-Swift_Laboratories_Ltd\" title=\"Why Investors Are Watching Ind-Swift Laboratories Ltd.\">Why Investors Are Watching Ind-Swift Laboratories Ltd.<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-ind-swift-laboratories-ltd-share-near-52-week-consecutive-high-2026\/#About_Ind-Swift_Laboratories_Ltd\" title=\"About Ind-Swift Laboratories Ltd.\">About Ind-Swift Laboratories Ltd.<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-ind-swift-laboratories-ltd-share-near-52-week-consecutive-high-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-ind-swift-laboratories-ltd-share-near-52-week-consecutive-high-2026\/#What_does_Ind-Swift_Laboratories_Ltd_52_Week_High_Streak_mean\" title=\"What does Ind-Swift Laboratories Ltd. 52 Week High Streak mean?\">What does Ind-Swift Laboratories Ltd. 52 Week High Streak mean?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-ind-swift-laboratories-ltd-share-near-52-week-consecutive-high-2026\/#How_many_sessions_has_Ind-Swift_Laboratories_Ltd_stayed_near_its_high\" title=\"How many sessions has Ind-Swift Laboratories Ltd. stayed near its high?\">How many sessions has Ind-Swift Laboratories Ltd. stayed near its high?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-ind-swift-laboratories-ltd-share-near-52-week-consecutive-high-2026\/#What_is_the_current_price_of_Ind-Swift_Laboratories_Ltd\" title=\"What is the current price of Ind-Swift Laboratories Ltd.?\">What is the current price of Ind-Swift Laboratories Ltd.?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-ind-swift-laboratories-ltd-share-near-52-week-consecutive-high-2026\/#Did_Ind-Swift_Laboratories_Ltd_set_a_new_52-week_high_today\" title=\"Did Ind-Swift Laboratories Ltd. set a new 52-week high today?\">Did Ind-Swift Laboratories Ltd. set a new 52-week high today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-ind-swift-laboratories-ltd-share-near-52-week-consecutive-high-2026\/#What_does_the_repeated_high_pattern_show\" title=\"What does the repeated high pattern show?\">What does the repeated high pattern show?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-ind-swift-laboratories-ltd-share-near-52-week-consecutive-high-2026\/#How_does_Ind-Swift_Laboratories_Ltd_compare_with_peers_on_valuation\" title=\"How does Ind-Swift Laboratories Ltd. compare with peers on valuation?\">How does Ind-Swift Laboratories Ltd. compare with peers on valuation?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-ind-swift-laboratories-ltd-share-near-52-week-consecutive-high-2026\/#What_do_the_fundamentals_show_for_Ind-Swift_Laboratories_Ltd\" title=\"What do the fundamentals show for Ind-Swift Laboratories Ltd.?\">What do the fundamentals show for Ind-Swift Laboratories Ltd.?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-ind-swift-laboratories-ltd-share-near-52-week-consecutive-high-2026\/#What_should_investors_monitor_next\" title=\"What should investors monitor next?\">What should investors monitor next?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/why-ind-swift-laboratories-ltd-share-near-52-week-consecutive-high-2026\/#Track_Ind-Swift_Laboratories_Ltd_INDSWFTLA_Share_Price_on_Univest\" title=\"Track Ind-Swift Laboratories Ltd. (INDSWFTLA) Share Price on Univest\">Track Ind-Swift Laboratories Ltd. (INDSWFTLA) Share Price on Univest<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Ind-Swift_Laboratories_Ltd_52_Week_High_Streak_Consecutive_High_Analysis\"><\/span><strong>Ind-Swift Laboratories Ltd. 52 Week High Streak: Consecutive High Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 416.25<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 408.3<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">+Rs 7.95 (+1.95%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 400.15<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 417.7<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 400.15<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 3,518.03 crore<\/td>\n<\/tr>\n<\/table>\n<p>Ind-Swift Laboratories Ltd. (INDSWFTLA) traded at Rs 416.25 versus the previous close of Rs 408.3, a rise of 1.95%. The stock opened at Rs 400.15, reached a high of Rs 417.7 and touched a low of Rs 400.15.<\/p>\n<p>Ind-Swift Laboratories Ltd. Share Price Today showed a measured move higher from the previous close, with the stock at <strong>Rs 416.25<\/strong> versus <strong>Rs 408.30<\/strong> previously. That is a gain of <strong>Rs 7.95<\/strong> or <strong>1.95%<\/strong> in the latest session, and it kept Ind-Swift Laboratories Ltd. 52 Week High Streak intact for a second straight session. The stock opened at <strong>Rs 400.15<\/strong> and touched a high of <strong>Rs 417.70<\/strong>, leaving the latest price close to the top of the day\u2019s range.<\/p>\n<p>This matters because the stock is not only near its 52-week high once; it has now stayed in that zone across consecutive sessions. The current market capitalisation of <strong>Rs 3,518.03 crore<\/strong> places the company in a clearly defined mid-sized bracket by value, and the repeated near-high pattern remains the main market news today. Ind-Swift Laboratories Ltd. Stock News around this move is therefore best read as a streak story first, not a single-session breakout story.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_the_Repeated_52-Week_Highs_Show\"><\/span><strong>What the Repeated 52-Week Highs Show<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Ind-Swift Laboratories Ltd. 52 Week High Streak indicates that the stock has stayed within 2% of its one-year peak for a second straight session, with a cumulative move of <strong>2.89%<\/strong> across the streak. The latest high of <strong>Rs 417.70<\/strong> is the current 52-week high, and the latest price action shows that the stock remains close to that level rather than far below it.<\/p>\n<p>What the Repeated 52-Week Highs Show is not a question of certainty about the cause. The latest Univest data confirms the price pattern, but it does not identify a company-specific reason for the continued trade near the peak. For readers following Stocks Hitting 52 Week Highs, the useful takeaway is that this is a persistent near-high setup, not a one-off tick above a prior level. Ind-Swift Laboratories Ltd. New One Year High Again is therefore a fair descriptive phrase, but only in the sense of repeated proximity, not a claim of an all-time record.<\/p>\n<p>Ind-Swift Laboratories Ltd. Share Price Update also matters in context because the streak is happening with a day range that stayed contained around the current level. In practical terms, the stock has held its position near the yearly high across back-to-back sessions, and that is what separates a consecutive 52-week high pattern from ordinary intraday noise.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Ind-Swift_Laboratories_Ltd_INDSWFTLA_Fundamental_Analysis\"><\/span><strong>Ind-Swift Laboratories Ltd. (INDSWFTLA) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 3,518.03 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">61.94x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.52x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.47%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 6.59<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 161.89<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0%<\/td>\n<\/tr>\n<\/table>\n<p>Ind-Swift Laboratories Ltd. (INDSWFTLA) fundamental metrics show P\/E 61.94x, P\/B 2.52x, ROE 3.47%, ROCE 4%. These figures provide context only and are not a buy or sell signal.<\/p>\n<p>Ind-Swift Laboratories Ltd. has a market capitalisation of Rs 3518.03 crore, which gives readers a sense of company size before judging valuation. On valuation, P\/E at 61.94x, P\/B at 2.52x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 3.47% and ROCE of 4%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 6.59, book value per share of Rs 161.89, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P\/E of 27.91x, median ROE of 11.74%, median ROCE of 13.63%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">61.94x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">27.91x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">41.51x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0x to 707.31x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.52x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.88x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.47%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.74%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.63%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 3,518.03 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 782.41 crore<\/td>\n<\/tr>\n<\/table>\n<p>Ind-Swift Laboratories Ltd. (INDSWFTLA) is classified under sector: Healthcare and industry: Pharmaceuticals &amp; Drugs.<\/p>\n<p>Ind-Swift Laboratories Ltd. (INDSWFTLA) has a P\/E ratio of 61.94x, which is above the benchmark median of 27.91x, a difference of +121.93%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Ind-Swift Laboratories Ltd. (INDSWFTLA) has a ROE of 3.47%, which is below the benchmark median of 11.74%, a difference of -70.44%. Ind-Swift Laboratories Ltd. (INDSWFTLA) has a ROCE of 4%, which is below the benchmark median of 13.63%, a difference of -70.65%.<\/p>\n<p>Track stocks reaching yearly peaks through the <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/solara\/solara-active-pharma-sciences-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Solara Active Pharma Sciences Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SOLARA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3,556.79<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">0<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2.8<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-0.63<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.61<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/advenzymes\/advanced-enzyme-technologies-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Advanced Enzyme Technologies Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ADVENZYMES<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3,263.54<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.16<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1.91<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.43<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">15.27<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/kpl\/kwality-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Kwality Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">KPL<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3,809.57<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">45.84<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">10.42<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">22.67<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">24.01<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/unichemlab\/unichem-laboratories-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Unichem Laboratories Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">UNICHEMLAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3,873.72<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">12.41<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1.37<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">9.81<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">10.68<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/aartidrugs\/aarti-drugs-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Aarti Drugs Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">AARTIDRUGS<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3,922.33<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">20.48<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2.45<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.36<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">12.04<\/td>\n<\/tr>\n<\/table>\n<p>Ind-Swift Laboratories Ltd. (INDSWFTLA) has a P\/E ratio of 61.94x compared with the displayed peer median of 19.16x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 3.47% compares with a peer median of 11.43% across the companies shown in the table. ROCE stood at 4% versus the displayed peer median of 12.04%, providing a capital-efficiency comparison. Ind-Swift Laboratories Ltd. (INDSWFTLA) has a market capitalisation of Rs 3,518.03 crore. Among the 5 peers shown, 4 have a larger market capitalisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Ind-Swift_Laboratories_Ltd\"><\/span><strong>Why Investors Are Watching Ind-Swift Laboratories Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>Ind-Swift Laboratories Ltd. 52 Week High Streak has continued for a second straight session, keeping the stock near its one-year peak.<\/li>\n<li>The cumulative move across the streak is <strong>2.89%<\/strong>, which gives a clearer view than a single-day change.<\/li>\n<li>The current price of <strong>Rs 416.25<\/strong> remains close to the latest high of <strong>Rs 417.70<\/strong>.<\/li>\n<li>The company\u2019s <strong>P\/E of 61.94<\/strong> is above the industry median, so valuation remains an important check.<\/li>\n<li>The healthcare and pharmaceuticals backdrop keeps Ind-Swift Laboratories Ltd. Share Price in focus among 52 Week High Stocks.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Ind-Swift_Laboratories_Ltd\"><\/span><strong>About Ind-Swift Laboratories Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Ind-Swift Laboratories Ltd. operates in the Pharmaceuticals &amp; Drugs industry within the Healthcare sector. The company\u2019s latest market capitalisation was <strong>Rs 3,518.03 crore<\/strong>, with an EPS of <strong>Rs 6.59<\/strong> and book value of <strong>Rs 161.89<\/strong>. Dividend yield was <strong>0%<\/strong>.<\/p>\n<p>Ind-Swift Laboratories Ltd. Stock Analysis today is shaped by the combination of a repeated near-52-week-high pattern and a valuation that sits above the industry median on earnings. For readers tracking Ind-Swift Laboratories Ltd. Share Price, the company remains in the spotlight because the price action and the reported fundamentals are being watched together, not separately.<\/p>\n<p><strong>Image ALT:<\/strong> Ind-Swift Laboratories Ltd. 52 Week High Streak analysis showing repeated near-yearly-high trading.<\/p>\n<p><strong>Conclusion:<\/strong> Ind-Swift Laboratories Ltd. 52 Week High Streak is the main market cue today, and the stock\u2019s repeated trade near its yearly peak keeps the move in focus for investors following the share price, valuation and sector context.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_does_Ind-Swift_Laboratories_Ltd_52_Week_High_Streak_mean\"><\/span><strong>What does Ind-Swift Laboratories Ltd. 52 Week High Streak mean?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> It means the stock has traded within 2% of its 52-week high for consecutive sessions. In this case, the streak has lasted for a second straight session, which keeps the yearly-high pattern in focus for readers tracking the share price.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_many_sessions_has_Ind-Swift_Laboratories_Ltd_stayed_near_its_high\"><\/span><strong>How many sessions has Ind-Swift Laboratories Ltd. stayed near its high?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The stock has stayed near its 52-week high for two consecutive sessions. The streak label provided for this event is second straight session, and the cumulative move across that period is 2.89%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_current_price_of_Ind-Swift_Laboratories_Ltd\"><\/span><strong>What is the current price of Ind-Swift Laboratories Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The latest price was Rs 416.25 as of 29 September 2026 at 9:23 AM IST. That level kept the stock very close to its latest 52-week high.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Did_Ind-Swift_Laboratories_Ltd_set_a_new_52-week_high_today\"><\/span><strong>Did Ind-Swift Laboratories Ltd. set a new 52-week high today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The latest figures show the stock trading near its 52-week high, but they do not support saying it set a new high today. The correct reading is that it remained close to the peak across back-to-back sessions.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_does_the_repeated_high_pattern_show\"><\/span><strong>What does the repeated high pattern show?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> It shows persistence near the yearly peak across consecutive sessions. The figures confirm the price pattern, but they do not establish a company-specific catalyst for why the stock kept trading in that zone.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Ind-Swift_Laboratories_Ltd_compare_with_peers_on_valuation\"><\/span><strong>How does Ind-Swift Laboratories Ltd. compare with peers on valuation?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The company\u2019s P\/E of 61.94 is above the industry median of 27.91. That makes it richer than several peer names in the same industry comparison set, even though its P\/B is below the industry median.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_do_the_fundamentals_show_for_Ind-Swift_Laboratories_Ltd\"><\/span><strong>What do the fundamentals show for Ind-Swift Laboratories Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The latest figures show ROE of 3.47%, ROCE of 4%, P\/B of 2.52, EPS of Rs 6.59 and book value of Rs 161.89. These numbers give a mixed fundamental picture alongside the repeated high pattern.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_should_investors_monitor_next\"><\/span><strong>What should investors monitor next?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors can watch whether the stock keeps trading near the same yearly peak while also tracking future financial results and valuation context. The repeated-high pattern is important, but it should be read together with the company\u2019s operating metrics and peer comparison.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What does Ind-Swift Laboratories Ltd. 52 Week High Streak mean?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"It means the stock has traded within 2% of its 52-week high for consecutive sessions. In this case, the streak has lasted for a second straight session, which keeps the yearly-high pattern in focus for readers tracking the share price.\"}},{\"@type\":\"Question\",\"name\":\"How many sessions has Ind-Swift Laboratories Ltd. stayed near its high?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The stock has stayed near its 52-week high for two consecutive sessions. The streak label provided for this event is second straight session, and the cumulative move across that period is 2.89%.\"}},{\"@type\":\"Question\",\"name\":\"What is the current price of Ind-Swift Laboratories Ltd.?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The latest price was Rs 416.25 as of 29 September 2026 at 9:23 AM IST. That level kept the stock very close to its latest 52-week high.\"}},{\"@type\":\"Question\",\"name\":\"Did Ind-Swift Laboratories Ltd. set a new 52-week high today?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The latest figures show the stock trading near its 52-week high, but they do not support saying it set a new high today. The correct reading is that it remained close to the peak across back-to-back sessions.\"}},{\"@type\":\"Question\",\"name\":\"What does the repeated high pattern show?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"It shows persistence near the yearly peak across consecutive sessions. The figures confirm the price pattern, but they do not establish a company-specific catalyst for why the stock kept trading in that zone.\"}},{\"@type\":\"Question\",\"name\":\"How does Ind-Swift Laboratories Ltd. compare with peers on valuation?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The company\u2019s P\/E of 61.94 is above the industry median of 27.91. That makes it richer than several peer names in the same industry comparison set, even though its P\/B is below the industry median.\"}},{\"@type\":\"Question\",\"name\":\"What do the fundamentals show for Ind-Swift Laboratories Ltd.?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The latest figures show ROE of 3.47%, ROCE of 4%, P\/B of 2.52, EPS of Rs 6.59 and book value of Rs 161.89. These numbers give a mixed fundamental picture alongside the repeated high pattern.\"}},{\"@type\":\"Question\",\"name\":\"What should investors monitor next?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Investors can watch whether the stock keeps trading near the same yearly peak while also tracking future financial results and valuation context. The repeated-high pattern is important, but it should be read together with the company\u2019s operating metrics and peer comparison.\"}}]}<\/script><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Track_Ind-Swift_Laboratories_Ltd_INDSWFTLA_Share_Price_on_Univest\"><\/span><strong>Track Ind-Swift Laboratories Ltd. (INDSWFTLA) Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/indswftla\/ind-share-price-today\">Ind-Swift Laboratories Ltd. (INDSWFTLA) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, yearly-high lists and related market analysis.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ind-Swift Laboratories Ltd. Share Price trades near its 52-week high at Rs 416.25, marking a 1.95% rise today. Market cap stands at Rs 3,518.03 crore.<\/p>\n","protected":false},"author":38,"featured_media":275806,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-275809","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["275806"],"rank_math_title":["Ind-Swift Laboratories Ltd. 52 Week High Streak Analysis"],"rank_math_description":["Ind-Swift Laboratories Ltd. stays near its yearly peak for a second straight session. Read the streak move, valuation, sector view and peers."],"rank_math_focus_keyword":["Ind-Swift Laboratories Ltd. 52 Week High Streak"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/ind-swift-laboratories-ltd-indswftla-52-week-high-streak-second-straight-session.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/275809","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/38"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=275809"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/275809\/revisions"}],"predecessor-version":[{"id":275811,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/275809\/revisions\/275811"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/275806"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=275809"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=275809"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=275809"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}